Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michaela Arndt"'
Autor:
Narges Seyfizadeh, David Kalbermatter, Thomas Imhof, Moritz Ries, Christian Müller, Leonie Jenner, Elisabeth Blumenschein, Alexandra Yendrzheyevskiy, Frank Grün, Kevin Moog, Daniel Eckert, Ronja Engel, Philipp Diebolder, Mohamed Chami, Jürgen Krauss, Torsten Schaller, Michaela Arndt
Publikováno v:
Journal of Biomedical Science, Vol 31, Iss 1, Pp 1-22 (2024)
Abstract Background Infections with Herpes simplex virus (HSV)-1 or -2 usually present as mild chronic recurrent disease, however in rare cases can result in life-threatening conditions with a large spectrum of pathology. Monoclonal antibody therapy
Externí odkaz:
https://doaj.org/article/90dc32068a724229a0d3541e5d8a5ec7
Autor:
Antje Blank, Nicolas Hohmann, Marlen Dettmer, Anette Manka‐Stuhlik, Gerd Mikus, Felicitas Stoll, Marlies Stützle‐Schnetz, Daniel Thomas, Evelyn Exner, Beate Schmitt‐Bormann, Torsten Schaller, Rico Laage, Oliver Schönborn‐Kellenberger, Michaela Arndt, Walter E. Haefeli, Jürgen Krauss
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 10, Pp 2366-2377 (2022)
Abstract HDIT101 is a first‐in‐class humanized monoclonal antibody recognizing a conserved epitope in glycoprotein B, a target present on the surface of herpes simplex virus 1 (HSV‐1) and HSV‐2 particles as well as on virus‐infected cells.
Externí odkaz:
https://doaj.org/article/76662fa3327b4df79ec9dca274ca9822
Autor:
Margaux Fresnais, Rémi Longuespée, Max Sauter, Torsten Schaller, Michaela Arndt, Jürgen Krauss, Antje Blank, Walter E. Haefeli, Jürgen Burhenne
Publikováno v:
ACS Omega, Vol 5, Iss 38, Pp 24329-24339 (2020)
Externí odkaz:
https://doaj.org/article/e7c9c27da8eb4f9089f3fc091dd9fb20
Autor:
Jürgen Krauss, Rémi Longuespée, Antje Blank, Walter E. Haefeli, Margaux Fresnais, Michaela Arndt, Jürgen Burhenne, Torsten Schaller, Max Sauter
Publikováno v:
ACS Omega, Vol 5, Iss 38, Pp 24329-24339 (2020)
Multiple therapeutic monoclonal antibodies (mAbs) are currently under development or in (pre)clinical study phases to reach regulatory approval. Among these, a new mAb against herpes simplex virus, HDIT101, was recently tested in healthy volunteers d
Publikováno v:
Blood. 94:2562-2568
CD16/CD30 bispecific monoclonal antibodies can induce remissions of Hodgkin’s disease refractory to chemo- and radiotherapy. However, the development of human antimouse immunoglobulin antibodies and allergic reactions precludes repeated application
Autor:
Michaela, Arndt, Jürgen, Krauss
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 207
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 207